Viewing Study NCT00756860


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-26 @ 6:15 AM
Study NCT ID: NCT00756860
Status: COMPLETED
Last Update Posted: 2012-06-04
First Post: 2008-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (RenagelĀ®)
Sponsor: Amgen Research (Munich) GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module